Hinog, Kiara .
HRN: 22-39-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/05/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/05/2023
04/12/2023
IV
150mg
Q6H
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes